Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Dersalazine, a PAF antagonist and TNFα inhibitor, is used potentially for the treatment of ulcerative colitis. It showed anti-inflammatory effect in reactivated colitis in rats, as evidenced by a significant reduction in MPO activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 8-10 weeks | $ 2,120.00 | |
50 mg | 8-10 weeks | $ 2,780.00 | |
100 mg | 8-10 weeks | $ 3,700.00 |
Description | Dersalazine, a PAF antagonist and TNFα inhibitor, is used potentially for the treatment of ulcerative colitis. It showed anti-inflammatory effect in reactivated colitis in rats, as evidenced by a significant reduction in MPO activity. |
Synonyms | UR12746, Dersalazine, UR 12746S (sodium salt), UR-12746S (sodium salt), UR-12746 |
Molecular Weight | 623.669 |
Formula | C35H32N6NaO4 |
CAS No. | 367249-56-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Dersalazine sodium 367249-56-7 UR12746 UR 12746 Dersalazine UR 12746S (sodium salt) UR 12746S UR-12746S UR-12746S (sodium salt) UR-12746 inhibitor inhibit